Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Rowland

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Journal of Neuroscience Methods|December 27, 2017
Miniature pig model of human adolescent brain white matter developmentMeghann C Ryan, Paul Sherman, Laura M Rowland, et al.
Human Brain Mapping|October 22, 2019
Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophreniaBhim M Adhikari, Juergen Dukart, Joerg F Hipp, et al.
Aviation, Space, and Environmental Medicine|July 16, 2005
Oculomotor responses during partial and total sleep deprivationLaura M Rowland, Maria L Thomas, David R Thorne, et al.
Brain and Behavior|February 28, 2017
Reproducibility of tract-based white matter microstructural measures using the ENIGMA-DTI protocolAshley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Human Brain Mapping|July 22, 2014
Combining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disordersAshley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2023
Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flowStephanie M Hare, Bhim M Adhikari, Chen Mo, et al.
Schizophrenia Bulletin|January 12, 2022
Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in SchizophreniaAnthony O Ahmed, Brian Kirkpatrick, Eric Granholm, et al.
Schizophrenia Research|April 19, 2019
Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigmsZachary B Millman, Keith Gallagher, Caroline Demro, et al.
Journal of Affective Disorders|October 29, 2020
Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7TGwenn S Smith, Georg Oeltzschner, Neda F Gould, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2016
Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A <sup>1</sup>H-MRS and pCASL studyS Andrea Wijtenburg, Susan N Wright, Stephanie A Korenic, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Journal of Neuroscience Methods|December 27, 2017
Miniature pig model of human adolescent brain white matter developmentMeghann C Ryan, Paul Sherman, Laura M Rowland, et al.
Human Brain Mapping|October 22, 2019
Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophreniaBhim M Adhikari, Juergen Dukart, Joerg F Hipp, et al.
Aviation, Space, and Environmental Medicine|July 16, 2005
Oculomotor responses during partial and total sleep deprivationLaura M Rowland, Maria L Thomas, David R Thorne, et al.
Brain and Behavior|February 28, 2017
Reproducibility of tract-based white matter microstructural measures using the ENIGMA-DTI protocolAshley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Human Brain Mapping|July 22, 2014
Combining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disordersAshley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2023
Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flowStephanie M Hare, Bhim M Adhikari, Chen Mo, et al.
Schizophrenia Bulletin|January 12, 2022
Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in SchizophreniaAnthony O Ahmed, Brian Kirkpatrick, Eric Granholm, et al.
Schizophrenia Research|April 19, 2019
Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigmsZachary B Millman, Keith Gallagher, Caroline Demro, et al.
Journal of Affective Disorders|October 29, 2020
Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7TGwenn S Smith, Georg Oeltzschner, Neda F Gould, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2016
Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A <sup>1</sup>H-MRS and pCASL studyS Andrea Wijtenburg, Susan N Wright, Stephanie A Korenic, et al.
Pageof 14